Dr. Brahmbhatt has over two years developing and establishing downstream purification processes for clinical manufacturing of several gene therapy viral vectors. Dr. Brahmbhatt received her doctoral degree in biochemistry and biomedical sciences from McMaster University, where she investigated small molecule modulators of mitochondrial apoptotic proteins and authored four publications.